[ExI] Alzheimer’s

Keith Henson hkeithhenson at gmail.com
Mon Sep 5 06:04:12 UTC 2016


In its highest dose, the drug was recently shown to annihilate amyloid
plaques in the brains of a subset of the study’s 165 participants.
It could cost up to $2.5 billion dollars to test it widely, but the
investment might be worth the price tag: if it works, aducanumab could
treat people for Alzheimer’s before they even show symptoms.
http://www.pbs.org/wgbh/nova/next/body/plaque-pillaging-alzheimers-drug-advances-toward-promising-phase-iii-trial/?utm_medium=N/A&utm_medium=pbsofficial&utm_campaign=nova_next&linkId=28297637&utm_source=twitter&hootPostID=7214100121367f51f30a3f435d378fb6




More information about the extropy-chat mailing list